Prostate Cancer Early Detection, Version 1.2014

• DOI: 10.6004/jnccn.2014.0120
• Publication Date: 2017-04-14T16:05:47Z
• Authors: Peter R. Carroll; J. Kellogg Parsons; Gerald Andriole; Robert R. Bahnson; Daniel A. Barocas; William J. Catalona; Douglas M. Dahl; John W. Davis; Jonathan I. Epstein; Ruth B. Etzioni; Veda N. Giri; George P. Hemstreet; Mark H. Kawachi; Paul H. Lange; Kevin R. Loughlin; William Lowrance; Paul Maroni; James Mohler; Todd M. Morgan; Robert B. Nadler; Michael Poch; Chuck Scales; Terrence M. Shane...; Andrew J. Vickers; Robert Wake; Dorothy A. Shead; Maria Ho
• Keywords: Prostate biopsy; Cancer Detection

The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations men choosing to participate in an early detection program prostate cancer. These Insights highlight notable recent updates. Overall, the 2014 update represents a more streamlined and concise set of recommendations. panel stratified age ranges at which initiating testing cancer should be considered. Indications biopsy include both cutpoint use multiple risk variables combination. In addition other biomarkers specificity, Health Index has been included aid decisions certain men, given FDA approvals.